Cart
sales@molnova.com
3-OXO-URS-12-EN-28-OIC ACID METHYL ESTER
CAS No. 989-72-0
3-OXO-URS-12-EN-28-OIC ACID METHYL ESTER( ——— )
Catalog No. M39325 CAS No. 989-72-0
Ursonic acid methyl ester is an esterified derivative of Ursolic acid. Ursonic acid methyl ester shows growth inhibitory activity against four tumor cell lines, HL-60, BGC, Bel-7402 and Hela with ED50 values of>100 μg/ml.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 250 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-OXO-URS-12-EN-28-OIC ACID METHYL ESTER
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrsonic acid methyl ester is an esterified derivative of Ursolic acid. Ursonic acid methyl ester shows growth inhibitory activity against four tumor cell lines, HL-60, BGC, Bel-7402 and Hela with ED50 values of>100 μg/ml.
-
DescriptionUrsonic acid methyl ester is an esterified derivative of Ursolic acid. Ursonic acid methyl ester shows growth inhibitory activity against four tumor cell lines, HL-60, BGC, Bel-7402 and Hela with ED50 values of>100 μg/ml.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number989-72-0
-
Formula Weight468.722
-
Molecular FormulaC31H48O3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chao-Mei Ma, et al. The cytotoxic activity of ursolic acid derivatives. Eur J Med Chem. 2005 Jun;40(6):582-9.?
molnova catalog
related products
-
Insulin Receptor (11...
Insulin Receptor (1142 - 1153), Amide
-
Sanggenol R
Sanggenol R
-
Danshenxinkun A
Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental adaptation and nervous system.
